DETAILED NOTES ON SUVOREXANT

apalutamide will minimize the level or result of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a solid CYP3A4 inducer, with medication which have been CYP3A4 substrates can result in reduce exposure to these medicines.Observe Intently (one)ribociclib will increase